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ABSTRACT (300 words [300 word limit]) 
Background: Annual vaccination is the most effective way to prevent and control the health and economic 
burden caused by seasonal influenza. Healthcare workers (HCWs) play a crucial role in vaccine acceptance and 
advocacy for their patients. This study explored the drivers of HCWs’ vaccine acceptance and advocacy in six 
European countries. 
Methods: Healthcare workers (mainly general practitioners, specialist physicians, and nurses) voluntarily 
completed a questionnaire in Bulgaria (N=485), Czech Republic (N=518), Kosovo (N=466), Poland (N=772), 
Romania (N=155), and the United Kingdom (N=80). Twelve-item scales were used to analyse sentiment clusters 
for influenza vaccination acceptance and engagement with vaccination advocacy. Past vaccination behaviour 
and patient recommendation were also evaluated. All data were included in a single analysis. 
Results: For vaccination acceptance, the main cluster (engaged sentiment: 68%) showed strong positive attitudes 
for influenza vaccination. A second cluster (hesitant sentiment: 32%) showed more neutral attitudes. Cluster 
membership was predicted by country of origin and age. The odds ratio for past vaccination in the engaged 
cluster was 39.6 (95% CI 12.21–128.56) although this varied between countries. For vaccination advocacy, the 
main cluster (confident sentiment: 73%) showed strong positive attitudes towards advocacy; a second cluster 
(diffident sentiment: 27%) showed neutral attitudes. Cluster membership was predicted by country of origin, age 
and profession, with specialist physicians being the least likely to belong to the confident sentiment cluster. 
HCWs characterised by confident advocacy sentiments were also more likely recommend flu vaccination. 
Again, this association was moderated by country of origin. 
Conclusions: These data show that there is room to improve both vaccination acceptance and advocacy rates in 
European HCWs, which would be expected to lead to higher rates of HCW vaccination. Benefits that could be 
expected from such an outcome are improved advocacy and better control of morbidity and mortality related to 
seasonal influenza infection. 
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INTRODUCTION 
In the European Union approximately 25-100 million individuals are infected by the seasonal influenza 
virus each year [1] and approximately 180 million individuals are at risk of serious complications if infected [1–
3]. Vaccination is widely accepted by infectious disease specialists as being the most effective means of 
preventing seasonal influenza infection. The World Health Organisation (WHO) recommends annual 
vaccination for high risk groups as well as for healthcare workers (HCWs) [4]. However, specific 
recommendations and coverage rates may vary widely between countries in the EU [5–7]. 
Healthcare workers, particularly General Practitioners (GPs) and nurses, play a crucial role in 
vaccination decisions not only for themselves but also for their patients [8–10]. Recently there has been 
increasing awareness of hesitancy in the wider population towards vaccination in general and in seasonal 
influenza vaccination in particular, including by some HCWs [8,10–16]. People’s willingness to engage in any 
activity is driven by both external motivations (what is required of them) and autonomous motivations (what 
they feel empowered to do). Previous studies have demonstrated the suitability of using questionnaires to 
evaluate HCW attitudes to seasonal influenza vaccination [17] as well as to a range of other infectious diseases 
(e.g., measles, pertussis) [18]. Similarly, questionnaires have been used to predict seasonal influenza vaccination 
rates among HCWs. 
The present study departs from the traditional cognitive approach of behaviour change models such as the 
Health Belief Model (HBM, [19]) or the Theory of Planned Behavior (TPB, [20]), which conceptualise 
vaccination uptake as a deliberate choice informed by a balanced consideration of cost and benefits where the 
decision-maker ask herself whether she needs vaccination. Instead, our theoretical framework seeks to better 
understand why HCWs may want to get vaccinated, and focuses instead on motivational factors driving 
behaviours [20]. The willingness of an individual to engage in any activity is driven by both external motivations 
(what is required from the individual) and autonomous motivations (based on the individual’s own assessment of 
the activity). Building upon the Cognitive Model of Empowerment [21], we conceive of the willingness of an 
individual to engage in vaccination uptake and vaccination advocacy without external pressure as determined by 
four personal assessments: the value/importance of the act, its impact/effectiveness, HCWs’ feeling of 
autonomy/choice regarding the activity, and their knowledge of the activity. The aim of this study was to gauge 
HCWs level of engagement with influenza vaccination and vaccination advocacy and to assess whether 
engagement contributed to seasonal influenza vaccination uptake as well as advocacy behaviour across countries. 
To achieve this, we used two recently developed scales [22] and collected data from HCWs in 6 European 
countries, combined into a single analysis. 
MATERIALS AND METHODS 
Participants 
Participants were HCWs from 6 European countries (Bulgaria, Czech Republic, Kosovo, Poland, 
Romania, and the United Kingdom). Participants were recruited via opportunity sampling with a minimum 
overall target of 250 HCWs per professional category (general practitioner, specialist physician, or nurse). 
Design and procedure 
Data collection took place between October 2014 and December 2015. A total of 2541 participants 
voluntarily completed the survey in either via an online questionnaire or a paper-based version of the 
questionnaire. The data were screened for outliers on both the MoVac-flu and the MovAd scales. Cases with 
missing values (n=18) or flagged as multivariate outliers based on Malahanobis distances (n=47, p<0.001) were 
excluded from the analysis as this is an indication of careless responding [23]. The final sample included data 
from 2476 respondents. Bulgarian participants were recruited using paper questionnaires distributed at GP and 
preventative medicine conferences; Czech Republic participants were recruited using paper questionnaires 
distributed at seminars for GPs and inserted with a pre-paid return envelope in a magazine (Practicus) that is 
distributed to all GPs; Kosovan and Polish participants were recruited either online or using paper 
questionnaires; Romanian participants were recruited using paper questionnaires; UK participants were 
recruited via a HCWs’ study day in London. 
Measures 
Motors of influenza vaccination acceptance: MoVac-flu 
The 12-item MoVac-flu scale [22] measured the following sentiments: the sentiment that influenza 
vaccination is important, the sentiment that it is impactful, the feeling of knowing how influenza vaccination 
works, and the sentiment of autonomy regarding influenza vaccination decisions. Vaccine acceptance 
sentiments were measured on a 7-point scale (1=strongly disagree, 4=neither disagree nor agree, 7=strongly 
agree) to measure the participants’ thoughts about influenza vaccination (Cohen’s a=0.860). 
Motors of engagement with vaccination advocacy: MovAd 
The 12-item MovAd scale [22] measured the following sentiments: the sentiment that vaccination 
advocacy is important, the sentiment that it is impactful, the feeling of knowing how to advocate vaccination, 
and the sentiment of autonomy regarding the decision to advocate vaccination. Vaccine advocacy sentiments 
were measured on the same 7-point Likert scale (Cohen’s a=0.864). 
Behavioural measures 
Participants were asked whether they had received the influenza vaccine during the 2014/2015 season 
(autumn/winter) (immediate past behaviour). They were also asked to report how often they recommended the 
influenza vaccine to eligible patients (advocacy behaviour). 
Demographics 
Demographic data included participants’ age, gender, and professional category (general practitioner, 
specialist physician or nurse). Table 1 summarises the demographic data. 
RESULTS 
Preliminary analyses 
Descriptive statistics and correlations for the MoVac-flu and MovAd scales are reported in Table 2. 
Normality assumptions were met as most kurtosis and skewness scores were below the upper threshold of 3.29 
for large samples [24]. The only exception was the MoVac-flu item 4.1 of the Autonomy dimension (kurtosis = 
4.11). This deviation was corrected by using power transformation (λ = 2). 
Motors of flu vaccination acceptance: MoVac-flu 
Responses to the MoVac-flu scale were analysed using the Two-Step Cluster procedure from IBM SPSS 
23.0, with 7 inputs: Importance (items 1, 2, 3), Impact (items 1, 2, 3), Feeling of Knowledge (items 1, 3), Depth 
of Knowledge (item 2), Choice (Autonomy item 1), Extrinsic Pressure (Autonomy item 2), Intrinsic Motivation 
(Autonomy item 3). To minimise order effects, cases were randomly ordered and cluster solutions were 
replicated using cases sorted in a different random order to confirm their stability. 
A first solution identified two clusters with an average silhouette measure of cohesion and separation of 
0.30, suggesting a “fair” clustering solution [25]. Items 1 and 2 of the Autonomy subscale as well as item 2 of 
the Feeling of Knowledge subscale were of weaker predictor importance (PIs < 0.15). The analysis was repeated 
without these predictors. The new and final solution identified two clusters. It was stable and showcased the 
average silhouette measure of cohesion and separation raised to 0.60, suggesting a “good” clustering solution 
[25]. This final auto-clustering solution is presented in Table S1 in the Supplementary Results. Figure 1 presents 
the mean agreement ratings for each predictor as a function of cluster membership as well as the distribution of 
respondents across countries. The first sentiment cluster profile is the largest (N = 1675, 68%). It is 
characterised by a strong sense that the influenza vaccine is important and impactful, a strong feeling of 
knowledge regarding the vaccine, and a strong sense of autonomy. This sentiment profile was labelled 
“engaged”. By contrast, the second sentiment cluster is characterised by a neutral, slightly negative, view of the 
importance of the influenza vaccine and a mitigated view of its impact. This sentiment cluster is also associated 
with weak feelings of knowledge and no clear sense of autonomy (intrinsic motivation). It was labelled 
“hesitant”. A one-way multivariate analysis of variance (MANOVA) confirmed all four dimensions of 
sentiments towards the influenza vaccination were highly differentiated between clusters,  
F(4, 2471)=1445.2, Wilk’s L=0.30, p < .001, hp2=0.70 (see Table S2). 
Next, we examined whether demographic statistics were predictive of sentiments. We conducted a binary 
logistic regression with membership to the engaged sentiment cluster as a discrete outcome (1=belong to 
engaged cluster, 0=belong to hesitant cluster) and with country of origin, age, gender, and profession as 
indicators (see Tables S3 and S4 for a complete summary). Country of origin was a significant predictor of 
membership, Wald !2 (5)=67.81, p<0.001. All countries were significantly less likely to be represented in the 
“engaged” cluster compared to Bulgarian respondents, who were the most likely to be characterised by this 
sentiment. Notably, most Romanian respondents were characterised by a hesitant sentiment. They were 7.81 
times less likely to be characterised by an “engaged” sentiment compared to the Bulgarian respondents. Age 
was the only other significant predictor of cluster membership. Older respondents more likely to belong to the 
engaged cluster than younger ones, with a 4% increase in the odds of being in the “engaged” cluster for every 
year increase in age, OR=1.04, 95% CI [1.03, 1.05], B=.04, SE=0.004, Wald !2 (1)=65.9, p<0.001. 
Next, we examined whether membership to the “engaged” sentiment cluster was a predictor of past 
vaccination behaviour against the flu, and whether this varied in each country. Figure 2 plots the percentage of 
HCWs reporting being vaccinated against the flu as a function of sentiment cluster (engaged vs. hesitant) and 
country of origin. We conducted a binary logistic regression with past vaccination against the flu as a discrete 
outcome (1 = vaccinated, 0 = not vaccinated) and with sentiment cluster, and sentiment cluster ´ country as 
indicators. Overall, respondents characterised by the engaged sentiment towards flu vaccination were 39.6 times 
more likely to have been vaccinated in the past compared to those characterised by the hesitant sentiment, 95% 
CI [12.21, 128.56], B=3.68, SE=0.60, Wald !2 (1)=37.5, p <0.001. The odds of vaccination in the “engaged” 
sentiment cluster varied across countries, Wald !2 (5)= 71.0, p<0.001. Specifically, whereas the probability of 
vaccination was higher for all respondents in the “engaged” sentiment cluster, this was less pronounced for 
Bulgarian respondents, OR=0.15, 95% CI [0.047, 0.501], B=–1.88, SE=0.61, Wald !2 (1)=9.6, p=0.002, 
Romanian, OR=0.11, 95% CI [0.03, 0.42], B=–2.20, SE=0.68, Wald !2(1)=10.5,  =0.001, and Kosovan 
respondents, OR=0.07, 95% CI [0.02, 0.22], B=–2.72, SE=0.61, Wald !2 (1)=20.1, p<0.001 (See Tables S5 and 
S6 for a complete results summary). 
Motors of vaccination advocacy: MovAd 
Responses to the MovAd scale were analysed using the same cluster procedure with 6 inputs: Importance 
(items 1, 2, 3), Impact (items 1, 2, 3), Feeling of Knowledge (items 1, 2, 3), Choice (Autonomy item 1), 
Extrinsic Pressure (Autonomy item 2), Obligation (Autonomy item 3). A first solution identified two clusters 
with an average silhouette measure of cohesion and separation of 0.40, suggesting a “fair” clustering solution 
(24). Items 1, 2, and 3 of the Autonomy subscale were of weak predictor importance (PIs<0.15). We re-ran the 
analysis without these predictors. The new and final solution identified two clusters. It was stable and 
showcased the average silhouette measure of cohesion and separation raised to 0.60, suggesting a “good” 
clustering solution [25]. This final auto-clustering solution is presented in Table S7 from the Supplementary 
Results. Figure 3 presents the mean agreement ratings for each predictor as a function of cluster membership as 
well as the distribution of respondents across countries. The first sentiment cluster profile is the largest (N = 
1800, 73% of respondents) and is characterised by a strong sense that vaccine advocacy is important and 
effective as well as a strong feeling of knowledge how to advocate vaccination. This advocacy sentiment profile 
was labelled “confident”. By contrast, the second sentiment cluster is characterised by a neutral view of the 
importance of advocacy and its effectiveness, as well as a much lower feeling of knowing how to advocate 
vaccination. This sentiment was labelled “diffident”. A one-way MANOVA confirmed a significant 
differentiation between the three clusters on all dimensions, F(3, 2472)=1790.1, Wilk’s L=0.32, p<0.001, 
hp2=0.69 (see Table S8). 
Next we examined whether demographic statistics were predictive of advocacy sentiments. We 
conducted a binary logistic regression with membership to the confident sentiment cluster as a discrete outcome 
(1=belong to confident cluster, 0=belong to diffident cluster) and with country of origin, age, gender, and 
profession as indicators (see Tables S9 and S10 for a complete summary). Country of origin was a significant 
predictor of membership, Wald !2 (5)=250.9, p<0.001. Respondents from Kosovo and Bulgaria were the most 
likely to be characterised by the confident sentiment towards advocacy. All other countries were significantly 
less likely to be represented in the confident cluster. Notably, most Romanian respondents were characterised by 
a diffident sentiment and they were 14.71 times less likely to be characterised by a confident sentiment towards 
advocacy compared to the Bulgarian respondents. Age also had a positive effect on the odds of belonging to the 
confident advocate cluster, with a 4% increase for every year increase in age, OR=1.04, 95% CI [1.03, 1.05], 
B=0.04, SE=0.01, Wald !2 (1)=62.3, p<0.001. The job of respondents also made a difference, Wald !2 (3)=10.7, 
p=0.014. General practitioners, nurses and other healthcare workers were significantly more likely to belong to 
the confident sentiment cluster compared to specialist physician (ORs=1.66, 1.67, and 2.23 respectively). 
Finally, we examined whether membership to the “confident” sentiment cluster was a predictor of the 
frequency with which HCWs recommended flu vaccination1, and whether this varied in each country using a 
Univariate Analysis of Variance (ANOVA) with the advocacy behaviour as a dependent variable and cluster 
membership and country of origin as independent variables. Figure 4 presents the mean values for the 
probability of recommending the flu vaccine (0=never, 100%=always) as a function of cluster membership 
(confident vs. diffident) and respondents’ country of origin. Overall, respondents characterised by the confident 
sentiment towards advocacy were more likely to recommend flu vaccination than those in the diffident cluster, 
Mconfident=78.4%, SD=17.8, Mdiffident=59.3%, SD=26.0, F(1, 2464)=204.61, p < .001, h2p=0.08. Countries also 
differed in how often they recommended the flu vaccination, F(5, 2464)=28.3, p<0.001, h2p=0.05 and the effect 
of advocacy cluster membership varied between countries, F(4, 2296)=7.55, h2p=0.02. 
  
                                                       
1 Advocacy behaviour was measured by asking HCWs how frequently they recommended the flu vaccine 
except for respondents in the Romanian survey who were asked to rate whether they “encouraged their patients 
to make flu vaccine” on a 7-point Likert scale. Their answers were recoded as a degree of ascent from 0 to 
100% to enable a comparison with responses from other countries. 
DISCUSSION 
Traditional theoretical frameworks conceptualise decision-making as the process of deciding whether 
one needs vaccination based on an evaluation of its potential benefits and associated costs. By contrast, we 
conceived of decisions to get vaccinated as a process driven by a consideration of whether one wants to be 
vaccinated based on an evaluation of the four dimensions of motivated behaviour identified by the CME [21]: 
the feeling of value, impact, knowledge, and autonomy. As such, our theoretical approach is better aligned more 
recent theoretical developments putting self-regulation at the centre stage [26,27]. 
A high level of HCW’s autonomous motivation towards vaccination and recommending vaccination is 
vital for high and sustained levels of influenza vaccination coverage, which varies across Europe and in some 
regions has waned in recent years [16]. Good vaccination coverage is essential to reduce the significant health 
and economic burden associated with influenza infection [4]. In this survey of HCW sentiments in Bulgaria, the 
Czech Republic, Kosovo, Poland, Romania, and the UK, vaccine acceptance was generally good in each 
country, with only a minority of HCWs in each country being characterised by a hesitant sentiment towards 
influenza vaccination. Similarly, the sentiment results for advocacy were generally encouraging, with a large 
majority of HCWs associated with a confident sentiment towards vaccination advocacy in all countries except 
for Poland and Romania. 
Our analyses uncovered two sentiment clusters, with most HCWs characterised by an ‘engaged 
sentiment’ which was significantly associated with past vaccination behaviour in all countries. This was 
especially apparent in the Czech Republic, Poland and UK samples where over 75% of HCWs identified as 
having an engaged sentiment towards influenza vaccination had been vaccinated against influenza in the past. 
For vaccination advocacy, HCWs characterised by a confident sentiment were significantly more likely to 
recommend influenza vaccination than those in the diffident cluster. 
Vaccine hesitancy is complex with diverse root causes that can change over time, for which there are 
currently very few effective interventions [28]. A recommendation from a HCW for influenza vaccination is a 
strong predictor of vaccine uptake [29–32]. However providers themselves may be hesitant to vaccinate 
themselves, may underestimate the influence of their recommendation, and may consider themselves not to be 
effective in managing a vaccine-related discussion [33]. Hesitancy may not be simply overcome by providing 
more information or even enhancing risk perception [34]. A recent trial of a physician-targeted communication 
intervention showed no effective increase in physician self-efficacy or decrease in parental hesitancy [35]. 
These examples highlight the difficulty of designing interventions to overcome vaccine hesitancy. The MoVac-
flu and MovAd scales facilitated the definition of meaningful, and potentially actionable clusters among HCWs. 
This segmentation by attitudes to both vaccination and vaccination advocacy may facilitate the tailoring of 
interventions or communications according to the underlying motivations and current behaviours of each 
segment [36]. Table S11 provides illustrative guidelines for developing an effective intervention aiming to 
increase vaccine confidence via the implementation of the “Listen-Understand-Engage” cycle [37] and the use 
of the MoVac and/or MovAd scales [22]. Future research may examine whether increased line manager vaccine 
acceptance and advocacy can be expected to positively affect that of HCWs generally [38]. Increased 
knowledge is also important for full engagement [39] so increasing HCWs’ sentiment of knowing could 
positively affect their sentiments towards influenza vaccination. 
Limitations of this study include the sampling strategy: all samples were recruited through convenience, 
or opportunistic sampling and thus cannot be considered as representative of the healthcare populations in the 
respective countries. It is also possible that the voluntary nature of participation in this survey may have skewed 
the data in favour of acceptance and advocacy and it is assumed that those holding very negative views may 
have declined to take part. The validity of the generalisation of these data to other European countries, or 
globally, is also untested, and the range of healthcare context and vaccine cost in the different countries was not 
accounted for. 
Nevertheless, the MoVac-flu and MovAd surveys provided an effective tool to monitor, understand, and 
compare the proportions of HCWs who feel engaged regarding flu vaccination and feel confident in advocating 
the vaccine. To our knowledge this is one of the first attempts to measure self-perceived efficacy in advocating 
vaccination. These tools could be used to design and measure outcomes of HCW-focused interventions that aim 
to increase provider confidence in influenza vaccination and in recommending influenza vaccination. 
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Table 1 Demographic characteristics of the samples 
    Country   
Variable BGR CZE GBR POL ROU XKX TOTAL 
N   485 518 80 772 155 466 2476 
Age        
  M 49.38 50.98 49.81 48.63 35.84 45.5 47.92 
  SD 7.47 12.16 9.78 11.53 9.39 9.2 10.98 
  Minimum 23 18 20 23 19 22 18 
  Maximum 70 81 67 83 62 63 83 
  18–29 years (%) 3.30 6.58 5.56 6.74 37.01 4.29 7.42 
  30–49 years (%) 50.93 35.78 38.89 52.20 55.19 64.59 50.65 
  50–65 years (%) 45.57 48.94 54.17 33.68 7.79 31.12 37.71 
  Over 65 years (%) 0.21 8.70 1.39 7.38 0.00 0.00 4.22 
Gender        
  Female (n) 393 382 77 516 117 304 1789 
  Male (n) 92 136 2 256 37 162 685 
  Missing 0 0 1 0 1 0 2 
Profession        
  General practitioner 478 451 1 675 0 174 1779 
  Specialist physician 0 8 0 0 49 38 95 
  Nurse 2 13 76 84 73 224 472 
  Other 5 46 3 13 33 30 130 
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Table 2 Descriptive statistics, correlations, and coefficient alpha for MoVac-flu and MovAd sentiments 
                Correlations 
Sentiments M SD Skewness Kurtosis alpha   1 2 3 3.2 4.1 4.2 
MoVac-flu sentiments 
1. Importance 5.45 1.74 -1.09 0.31 0.90                           
2. Impact 5.86 1.42 -1.51 2.23 0.87   0.81***                    
3. Feeling of Knowledge 6.06 1.32 -1.74 0.68 0.862  0.72*** 0.79***                
  3.2 Depth of Knowledge3 5.61 2.11 -1.25 0.30   0.02 0.06** 0.12***            
4. Autonomy     0.16                      
  4.1. Choice1 6.23 1.48 -1.64 1.45 0.084  0.19*** 0.23*** 0.29*** 0.09***        
  4.2. Extrinsic Pressure 3.07 2.27 0.60 -1.19 0.334  0.05* -0.04* -0.01 -0.24*** 0.02     
  4.3. Intrinsic Motivation 5.74 1.96 -1.46 0.74 -0.074  0.048*** 0.53*** 0.44*** 0.05* 0.21*** -0.04* 
MovAd sentiments 
1. Importance 5.87 1.30 -1.32 1.30 0.83                           
2. Impact 5.67 1.20 -1.04 1.02 0.84   0.67***           
3. Feeling of Knowledge 5.85 1.25 -1.38 1.73 0.90   0.62*** 0.54***         
4. Autonomy     0.31               
  4.1. Choice 5.17 1.96 -0.82 -0.52 0.094  0.25*** 0.17*** 0.21***       
  4.2. Extrinsic Pressure 3.16 2.16 0.55 -1.15 0.274  0.07*** 0.07*** 0.03   0.18***   
  4.3. Obligation 5.85 1.55 -1.44 1.37 0.304  0.66*** 0.51*** 0.56***   0.16*** 0.05* 
* p<0.05                                     
** p<0.01                                     
*** p<0.001                                     
1Skewness, kurtosis, and correlations scores based on power-transformed variables (!=2). 
2Cohen's alpha if item 3.2 of the Feeling of Knowledge subscale for MoVac-flu is removed. 
33.2 Depth of Knowledge: "How the flu jab works to protect my health is a mystery to me" (reverse-coded).     
4Cohen's alpha if the corresponding item is removed. 
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Figure 1 MoVac-flu profiles for the “engaged” and “hesitant” clusters and their distributions across countries ordered from the most to the least represented in the “engaged” 
cluster 
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Figure 2 Percentage of healthcare workers reporting being vaccinated against influenza as a function of sentiment cluster (“engaged” vs. “hesitant” clusters) and country 
ordered from the smallest to the largest vaccination gap between “hesitant” and “engaged” sentiment clusters 
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Figure 3 MovAd profiles for the “confident” and “diffident” sentiment clusters and their distributions across countries ordered from the most to the least represented in the 
“confident” cluster 
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Figure 4 Mean probability that healthcare workers will recommend influenza vaccination as a function of advocacy sentiment cluster (“diffident” vs. “confident” clusters) 
and country ordered from the largest to the smallest gap in recommendation probability between “diffident” and “confident” sentiment clusters (100%=always recommend, 
0%=never recommend) 
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Table S1 Auto-clustering solution for the MoVac-flu scale 
Number of Clusters 
Schwarz's Bayesian 
Criterion (BIC) 
BIC 
Changea 
Ratio of BIC 
Changesb 
Ratio of Distance 
Measuresc 
1 6925.4    
2 3780.8 -3144.7 1.00 5.09 
3 3213.4 -567.3 0.18 1.59 
4 2880.2 -333.2 0.11 1.22 
5 2619.3 -261.0 0.08 1.26 
6 2424.0 -195.3 0.06 1.30 
aThe changes are from the previous number of clusters in the table. 
bThe ratios of changes are relative to the change for the two cluster solution. 
cThe ratios of distance measures are based on the current number of clusters against the previous number of clusters. 
 
Table S2 Predictor importance, and one-way analysis of variance of cluster profile distinctiveness for the MoVac-flu scale 
Predictors PI F(1, 2474) p η2p 
  Value (1, 2, 3) 1.00 3087.0 <0.001 0.56 
  Impact (1, 2, 3) 1.00 2566.8 <0.001 0.51 
  Feeling of Knowledge (1,3) 0.97 1822.3 <0.001 0.42 
  Intrinsic Motivation (3) 1.00 2050.4 <0.001 0.45 
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Table S3 Mean values and frequencies for predictor variables as a function of cluster membership for the MoVac-flu scale 
Predictors Engaged Hesitant "2(1) or t(2465) p 
Country (%)     
  BGR 79.8% 20.2% 172.2 <0.001 
  CZE 73.0% 27.0% 109.4 <0.001 
  XKX 66.3% 33.7% 49.6 <0.001 
  POL 66.1% 33.9% 79.7 <0.001 
  GBR 62.5% 37.5% 5.0 0.025 
  ROU 26.5% 73.5% 34.4 <0.001 
Age     
  M 49.7 44.2 12.0 <0.001 
  SD 10.4 11.2   
Female (%) 75.1% 71.0% 4.7 0.031 
Profession     
  Specialist physician 52.6% 47.4% 0.3 0.608 
  General practitioner 72.1% 27.9% 348.2 <0.001 
  Nurse 58.1% 41.9% 12.2 <0.001 
  Other 52.3% 47.7% 0.3 0.599 
Note. A t-test was used for the Age predictor variable; a Chi-square test was used for all other 
variables. 
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Table S4 Summary of the binary logistic regression analysis predicting membership to the “engaged” sentiment cluster towards flu vaccination 
Predictors B SE OR 95% CI Wald "2 df p 
Country (%)     67.8 5 <0.001 
  CZE -0.419 0.154 0.658 [0.49, 0.89] 7.4 1 0.007 
  XKX -0.595 0.178 0.552 [0.39, 0.78] 11.2 1 0.001 
  POL -0.698 0.140 0.497 [0.38, 0.66] 24.9 1 <0.001 
  GBR -0.657 0.314 0.519 [0.28, 0.96] 4.4 1 0.036 
  ROU -2.059 0.272 0.128 [0.08, 0.22] 57.5 1 <0.001 
Age 0.036 0.004 1.037 [1.03, 1.05] 65.9 1 <0.001 
Female (%) 0.199 0.107 1.220 [0.99, 1.51] 3.4 1 0.064 
Profession     1.5 3 0.680 
  General practitioner -0.227 0.283 0.797 [0.46, 1.39] 0.6 1 0.423 
  Nurse -0.235 0.274 0.790 [0.46, 1.35] 0.7 1 0.391 
  Other -0.385 0.319 0.680 [0.36, 1.27] 1.5 1 0.227 
Note. CI=confidence interval for odds ratio (OR). Reference category for Country=BGR. Reference category for Profession=Specialist Physician. R2=0.128 (Nagelkerke). 
Model "2(10)=237.8, p<0.001, -2LL=2862.7. 
 
Table S5 Frequencies for the MoVac-flu “engaged” cluster membership as a function of country and vaccination behaviour 
Predictors Vaccinated Not Vaccinated "2(1) p 
Engaged (%) 84.9% 40.9% 522.9 <0.001 
  Engaged | GBR 79.8% 14.3% 28.2 <0.001 
  Engaged | POL 83.8% 22.1% 269.0 <0.001 
  Engaged | CZE 94.6% 34.4% 218.8 <0.001 
  Engaged | BGR 90.1% 62.6% 53.2 <0.001 
  Engaged | ROU 44.1% 15.6% 15.2 <0.001 
  Engaged | XKX 77.7% 57.6% 20.8 <0.001 
Note. A Chi-square test was used for all variables. 
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Table S6 Summary of the binary logistic regression analysis predicting membership to the MoVac-flu “engaged” sentiment cluster towards flu vaccination 
Predictors B SE OR 95% CI Wald "2 df p 
Block 1        
MoVac Sentiment 2.10 0.10 8.14 [6.73, 9.85] 465.3 1 <0.001 
Block 2        
MoVac Sentiment 3.68 0.60 39.615267 [12.21, 128.56] 37.5 1 <0.001 
MoVac × Country     171.0 5 <0.001 
  POL -0.51 0.61 0.60 [0.18, 2.00] 0.7 1 0.406 
  CZE -1.16 0.61 0.31 [0.10, 1.04] 3.6 1 0.057 
  BGR -1.88 0.61 0.15 [0.047, 0.501] 9.6 1 0.002 
  ROU -2.20 0.68 0.11 [0.03, 0.42] 10.5 1 0.001 
  XKX -2.72 0.61 0.07 [0.02, 0.22] 20.1 1 <0.001 
Note. CI=confidence interval for odds ratio (OR). Reference category for Country=GBR. Block 1: R2=0.26 (Nagelkerke). Model "2(1)=526.9, p<0.001, -2LL=2789.5. 
Block 2: R2=0.34 (Nagelkerke). Block "2(5)=194.0, p<0.001, Model "2(6)=720.8, p<0.001, -2LL = 2595.6. 
Table S7 Auto-clustering solution for the MovAd scale 
Number of Clusters Schwarz's Bayesian Criterion (BIC) BIC Changea Ratio of BIC Changesb Ratio of Distance Measuresc 
1 5194.1    
2 3145.5 -2048.6 1.00 4.02 
3 2671.5 -474.0 0.23 1.32 
4 2322.7 -348.8 0.17 1.95 
5 2167.2 -155.6 0.08 1.31 
6 2059.8 -107.3 0.05 1.28 
aThe changes are from the previous number of clusters in the table. 
bThe ratios of changes are relative to the change for the two cluster solution. 
cThe ratios of distance measures are based on the current number of clusters against the previous number of clusters. 
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Table S8 Predictor importance, and one-way analysis of variance of cluster profile distinctiveness for the MovAd scale 
Predictors PI F(1, 2474) p η2p 
  Value (1, 2, 3) 1.00 3920.3 <0.001 0.61 
  Impact (1, 2, 3) 1.00 1891.1 <0.001 0.43 
  Knowledge (1, 2, 3) 1.00 1960.1 <0.001 0.44 
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Table S9 Mean values and frequencies for predictor variables as a function of cluster membership for the MovAd scale 
Predictors Confident Diffident "2(1) or t(2465) p 
Country (%)     
  XKX 92.7% 7.3% 339.9 <0.001 
  BGR 87.6% 12.4% 274.7 <0.001 
  GBR 86.3% 13.8% 42.1 <0.001 
  CZE 72.4% 27.6% 103.9 <0.001 
  POL 56.0% 44.0% 11.0 <0.001 
  ROU 46.5% 53.5% 0.8 0.377 
Age     
  M 49.0 44.9 8.4 <0.001 
  SD 10.4 11.9   
Female (%) 73.3 69.6 3.4 0.066 
Profession     
  Specialist physician 71.6% 28.4% 17.7 <0.001 
  General practitioner 71.3% 28.7% 323.8 <0.001 
  Nurse 79.9% 20.1% 168.5 <0.001 
  Other 70.0% 30.0% 20.8 <0.001 
Note. A t-test was used for the Age predictor variable; a Chi-square test was used for all other 
variables. 
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Table S10 Summary of the binary logistic regression analysis predicting membership to the “confident” sentiment cluster towards vaccination advocacy 
Predictors B SE OR 95% CI Wald "2 df p 
Country (%)     250.9 5 <0.001 
  BGR -0.467 0.247 0.627 [0.39, 1.02] 3.6 1 0.059 
  GBR -0.864 0.430 0.421 [0.18, 0.98] 4.0 1 0.045 
  CZE -1.556 0.223 0.211 [0.14, 0.33] 48.6 1 <0.001 
  POL -2.210 0.208 0.110 [0.07, 0.17] 112.5 1 <0.001 
  ROU -2.687 0.270 0.068 [0.04, 0.12] 99.2 1 <0.001 
Age 0.037 0.005 1.038 [1.03, 1.05] 62.3 1 <0.001 
Female (%) -0.159 0.112 0.853 [0.68, 1.06] 2.0 1 0.158 
Profession     10.7 3 0.007 
  General practitioner 0.509 0.188 1.664 [1.15, 2.40] 7.4 1 0.038 
  Nurse 0.514 0.247 1.671 [1.03, 2.71] 4.3 1 0.019 
  Other 0.800 0.341 2.225 [1.14, 4.34] 5.5 1 0.013 
Note. CI=confidence interval for odds ratio (OR). Reference category for Country=XKX. Reference category 
for Profession=Specialist Physician. R2=0.225 (Nagelkerke). Model "2(10)=416.0, p<0.001, -2LL=2463.9. 
 
 
 
  
28 
 
Table S11 Illustrative steps needed to develop effective interventions using the MoVac/MovAd scales and the “Listen-Understand-Engage” framework [1] 
Step Action Example 
1. Listen Survey Healthcare workers’ sentiments towards vaccination 
and/or vaccination advocacy in a given population using the 
MoVac/MovAd tools [2]. 
 
2. Understand Identify the key barriers against vaccination and/or advocacy 
through a Two-Step cluster profile of respondents. 
In the 2014-2015 survey reported in this study, the “Hesitant” 
cluster was most hesitant about the value of flu vaccination. 
3. Engage Identify, design, and implement an appropriate intervention 
function (e.g., education, persuasion, incentivizing, coercion, 
modelling; see [3]) 
Perception of importance may be influenced through 
persuasion. For example, belief persistence is known to be 
reduced if people can easily find counterarguments for their 
beliefs [4]. Engaging hesitant HCWs to give a few key 
reasons why flu vaccination might nevertheless be important 
could work implicitly to increase their perception of the 
importance of flu vaccination. 
4. Listen Carry out a post-test survey of HCWs’ sentiments towards 
vaccination and/or vaccination advocacy and vaccination behavior 
rates 
Post-intervention assessments are important to evaluate the 
impact of the interventions on staff engagement profile and to 
keep the cycle. A ‘gold standard’ for assessing interventions 
is a Solomon four-group design [5] which requires a 
randomized allocation to four groups: (1) pre-test – 
intervention -  post-test, (2) pre-test – post-test, (3) 
intervention - post-test, and (4) post-test. 
[1] Thomson A, Watson M. Listen, Understand, Engage. Sci Transl Med 2012;4:138ed6-138ed6. doi:10.1126/scitranslmed.3004264. 
[2] Vallée-Tourangeau G, Promberger M, Moon K, Wheelock A, Sirota M, Norton C, et al. Motors of influenza vaccination uptake and vaccination advocacy in healthcare workers: 
Development and validation of two short scales. Vaccine 2017. doi:10.1016/j.vaccine.2017.08.025. 
[3] Michie S, Van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci 2011;6:42. 
[4] Nestler S. Belief perseverance: The role of accessible content and accessibility experiences. Soc Psychol 2010;41:35–41. doi:10.1027/1864-9335/a000006. 
[5] Kool VK, Agrawal R. On Using Experimental Designs. In: Hegde DS, editor. Essays Res. Methodol., New Delhi: Springer India; 2015, p. 169–83. doi:10.1007/978-81-322-2214-9_8. 
 
